Want to see HK:2159 full AI Analyst Report?
2159 Stock Chart & Stats
HK$1.24
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.24
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.06 - HK$2.27
Previous CloseN/A
Volume32.00K
Average Volume (3M)143.19K
Market Cap
HK$459.20M
Enterprise ValueHK$426.92
Total Cash (Recent Filing)HK$99.36M
Total Debt (Recent Filing)HK$54.49M
Price to Earnings (P/E)48.8
Beta0.54
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding280,000,000
10 Day Avg. Volume118,880
30 Day Avg. Volume143,186
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio96.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Return To ProfitabilitySustained 48% top-line growth and a return to net profit indicate durable demand and improving unit economics. Over a 2–6 month horizon this revenue scale can support margin improvement initiatives, absorb fixed costs, and fund product or sales investments that reinforce competitive position.
Improved Leverage And Balance-sheet FlexibilityLower leverage after improvement to a 0.49 debt/equity ratio provides financial flexibility to invest organically or pursue partnerships. A more conservative capital structure reduces refinancing risk and preserves optionality for strategic spending without immediate solvency pressure.
Positive Operating And Free Cash Flow In 2025Achieving positive OCF and FCF demonstrates the business can generate internal funding after several prior cash-burning years. Even modest positive cash flow strengthens sustainability of operations, reduces near-term external financing needs, and supports reinvestment into scalable areas.
Bears Say
Very Thin Operating ProfitabilityAn operating margin near zero leaves little buffer for cost increases or weaker revenue, making profitability vulnerable to normal business volatility. Sustaining long-term growth while converting revenue into durable operating earnings will require meaningful margin expansion.
Unstable Cash-flow History And Sharp FCF DeclineA history of multi-year cash burn and a large YoY FCF decline indicate cash-generation inconsistency. This elevates refinancing and execution risk, pressures liquidity, and forces management to prioritize short-term cash fixes over long-term strategic investments.
Earnings Volatility And Modest ROEWide swings from profits to deep losses and a modest 8.7% ROE reflect inconsistent capital productivity. Persistent volatility undermines planning and investor confidence, complicates capital allocation, and raises the bar for proving sustainable, repeatable returns.
Mediwelcome Healthcare Management & Technology Inc. News
2159 FAQ
What was Mediwelcome Healthcare Management & Technology Inc.’s price range in the past 12 months?
Mediwelcome Healthcare Management & Technology Inc. lowest stock price was HK$1.06 and its highest was HK$2.27 in the past 12 months.
What is Mediwelcome Healthcare Management & Technology Inc.’s market cap?
Mediwelcome Healthcare Management & Technology Inc.’s market cap is HK$459.20M.
When is Mediwelcome Healthcare Management & Technology Inc.’s upcoming earnings report date?
Mediwelcome Healthcare Management & Technology Inc.’s upcoming earnings report date is Mar 31, 2027 which is in 236 days.
How were Mediwelcome Healthcare Management & Technology Inc.’s earnings last quarter?
Mediwelcome Healthcare Management & Technology Inc. released its earnings results on Jul 31, 2026. The company reported HK$0.073 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Mediwelcome Healthcare Management & Technology Inc. overvalued?
According to Wall Street analysts Mediwelcome Healthcare Management & Technology Inc.’s price is currently Overvalued.
Does Mediwelcome Healthcare Management & Technology Inc. pay dividends?
Mediwelcome Healthcare Management & Technology Inc. does not currently pay dividends.
What is Mediwelcome Healthcare Management & Technology Inc.’s EPS estimate?
Mediwelcome Healthcare Management & Technology Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mediwelcome Healthcare Management & Technology Inc. have?
Mediwelcome Healthcare Management & Technology Inc. has 280,000,000 shares outstanding.
What happened to Mediwelcome Healthcare Management & Technology Inc.’s price movement after its last earnings report?
Mediwelcome Healthcare Management & Technology Inc. reported an EPS of HK$0.073 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.796%.
Which hedge fund is a major shareholder of Mediwelcome Healthcare Management & Technology Inc.?
Currently, no hedge funds are holding shares in HK:2159
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mediwelcome Healthcare Management & Technology Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
116.98%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
115.62%
Trailing 12-Months
Company Description
Mediwelcome Healthcare Management & Technology Inc.
As an investment holding entity, Mediwelcome Healthcare Management & Technology Inc. delivers comprehensive marketing solutions for the healthcare sector within the People's Republic of China. Its service portfolio encompasses medical conference organization, patient education and screening programs, along with strategic marketing and advisory support. Additionally, the company provides Contract Research Organization (CRO) services, specifically focusing on patient recruitment and clinical data gathering. Furthermore, Mediwelcome manages a mobile application that facilitates internet hospital functionalities, including virtual follow-up consultations for physicians' current patients and electronic prescription services. Its diverse client base includes pharmaceutical firms, medical associations, and various foundations. Established in 2000, Mediwelcome Healthcare Management & Technology Inc. maintains its headquarters in Beijing, China.
Mediwelcome Healthcare Management & Technology Inc. (2159) Earnings & Revenues
Technical Analysis
Honliv Healthcare Management Group Co Ltd
―
Perfect Medical Health Management Limited
―
EC Healthcare
―
Yidu Tech, Inc.
―
Town Health International Medical Group Ltd.
―